• SHARE

Countries across the Asia Pacific are demurring on AstraZeneca PLC’s COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.

After guiding against the vaccine’s use in people under 50 and saying that it didn’t expect shipments from Europe to arrive on time, Australia’s government abandoned a pledge that everyone in the country would receive a first dose by October.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)